Stable pharmaceutical composition of 5-aza-2′-deoxycitidine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9669048
APP PUB NO 20160166593A1
SERIAL NO

14436572

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are ready to use, non-aqueous pharmaceutical compositions comprising 5-aza-2′-deoxycitidine and at least one aprotic solvent. The pharmaceutical compositions may further comprise at least one protic solvent. Also described are processes for preparing the pharmaceutical compositions and their use for the treatment of patients suffering from myelodysplastic syndromes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FRESENIUS KABI ONCOLOGY LIMITEDNEW DELHI 110 066

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chopra, Sunny Gurgaon, IN 3 9
Garg, Minakshi Gurgaon, IN 3 22
Khanna, Rajesh Gurgaon, IN 48 4058
Khattar, Dhiraj Gurgaon, IN 26 202
Motwani, Sanjay Gurgaon, IN 2 6

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00